These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 32858372

  • 1. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X, Zhou J, Quan L, Liang Y, Huang P, Chen F, Liu S.
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [Abstract] [Full Text] [Related]

  • 2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W, Zhang Y, Xia S.
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [Abstract] [Full Text] [Related]

  • 3. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
    Cui F, Luo P, Bai Y, Meng J.
    Technol Cancer Res Treat; 2021 Mar; 20():1533033821990007. PubMed ID: 33550957
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p.
    Shen D, Li J, Tao K, Jiang Y.
    Bioengineered; 2021 Dec; 12(1):3525-3538. PubMed ID: 34346845
    [Abstract] [Full Text] [Related]

  • 5. [Overexpression of lncRNA FEZF1-AS1 promotes progression of non-small cell lung cancer via the miR-130a-5p/CCND1 axis].
    Li F, Xiang J, Liu J, Wang X, Jiang H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May 20; 44(5):841-850. PubMed ID: 38862441
    [Abstract] [Full Text] [Related]

  • 6. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R, Hu T, Liu Y, He Y, Cao Y.
    Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 31912882
    [Abstract] [Full Text] [Related]

  • 7. NCK1-AS1 promotes the proliferation, migration, invasion, and EMT of non-small cell lung cancer by regulating the miR-361-5p/ADAM10 axis.
    Wu B, Wang Z, Xu H, Chu X, Jiang Q.
    Histol Histopathol; 2023 Dec 31; 38(12):1453-1464. PubMed ID: 36912070
    [Abstract] [Full Text] [Related]

  • 8. lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1.
    Cheng G, Li Y, Liu Z, Song X.
    Adv Clin Exp Med; 2021 Oct 31; 30(10):1043-1050. PubMed ID: 34610219
    [Abstract] [Full Text] [Related]

  • 9. Long noncoding RNA regulatory factor X3- antisense RNA 1 promotes non-small cell lung cancer via the microRNA-577/signal transducer and activator of transcription 3 axis.
    Hu Y, Zhao Z, Jin G, Guo J, Nan F, Hu X, Hu Y, Han Q.
    Bioengineered; 2022 Apr 31; 13(4):10749-10764. PubMed ID: 35475457
    [Abstract] [Full Text] [Related]

  • 10. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
    Jia YC, Wang JY, Liu YY, Li B, Guo H, Zang AM.
    Cell Biol Int; 2019 Apr 31; 43(4):384-393. PubMed ID: 30599080
    [Abstract] [Full Text] [Related]

  • 11. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
    Yu X, Lin Q, Liu F, Yang F, Mao J, Chen X.
    Int J Immunopathol Pharmacol; 2020 Apr 31; 34():2058738420958947. PubMed ID: 32969763
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z, Kun W, Xiaochun S, Lingling T.
    Apoptosis; 2021 Jun 31; 26(5-6):348-360. PubMed ID: 33974163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1.
    Zha LF, Zhang LD, Pan HM, Ma HD.
    Eur Rev Med Pharmacol Sci; 2021 Feb 31; 25(3):1351-1357. PubMed ID: 33629305
    [Abstract] [Full Text] [Related]

  • 18. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X.
    Exp Mol Pathol; 2021 Jun 31; 120():104633. PubMed ID: 33753110
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H.
    Cancer Biol Ther; 2018 Jul 03; 19(7):573-583. PubMed ID: 29667486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.